The Latin America, Middle East and Africa Nasogastric Tube Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
Healthcare professionals estimate the length of the tube required to reach the stomach or, on occasion, the upper portion of the small intestine using a variety of approaches. The length is related to the size of the body; therefore, it can be measured against other body distances. The NG tube installation does not require surgery and may be performed swiftly and safely in most patients. This is especially useful in emergencies, such as hazardous ingestion, when patients' stomachs must be pumped. In addition, it permits individuals with deteriorating health to receive enteral nourishment without surgery. It also has beneficial short-term applications, such as stomach decompression.
Decompression of the GI tract and gastric emptying are two common reasons for the placement of an NGT. NGTs can also deliver oral drugs like activated charcoal or radiographic contrast agents, enteral feeding solutions, and pharmaceuticals. A successful insertion requires careful planning for a safe NGT implantation. Before placement, this entails conducting an accurate patient assessment and communicating with the entire team.
The UAE government is considering developing a top-notch healthcare infrastructure a primary priority, leading to the sector's rapid development and expansion in recent years. Those supported by relatively high-income levels will seek higher quality healthcare as the prevalence of lifestyle diseases rises. The government's attention is being directed toward building healthcare infrastructure to meet this need. In addition, Dubai ought to become a regional hub for top-notch healthcare, so the UAE government is working to increase the number of medical tourists visiting the country. Due to this, the area is developing its healthcare system to better serve the people. The market players operating in the regional market are predicted to benefit significantly from growth opportunities.
The Brazil market dominated the LAMEA Nasogastric Tube Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $12.6 million by 2028. The Argentina market is experiencing a CAGR of 9.1% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 8.2% during (2022 - 2028).
Based on Indication, the market is segmented into Dysphagia, Chronic Kidney Disease, Inflammatory Bowel Disease (IBD), Esophageal Cancer, Stomach Cancer and Others. Based on Patient Type, the market is segmented into Adult, Geriatric and Pediatric. Based on Type, the market is segmented into Small-bore Feeding Tubes and Large-bore Feeding Tubes. Based on End-Use, the market is segmented into Hospitals & Nursing Homes and Home Care. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Nasogastric Tube Market is Projected to reach USD 669.5 Million by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Cardinal Health, Inc., QMD, Angiplast Pvt. Ltd., Securmed Spa, Vygon SAS, Andersen Products, Inc. (Weiler Abrasives Group), Guangdong Baihe Medical Technology Co., Ltd. and Poly Medicure Ltd.
By Indication
By Patient Type
By Type
By End-Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 